Retail & Mail Order Pharmacy was Medicure’s largest segment in fiscal 2025, bringing in $20.29M of $28.86M (70%).
| Segments [axis] | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| Marketing & Distribution Of Commercial Products | $15.28M | $12.12M | $11.08M | $8.57M | ||
| Retail & Mail Order Pharmacy | $7.78M | $9.58M | $10.83M | $20.29M | ||
| Total | $23.07M | $21.69M | $21.91M | $28.86M |
Medicure brought in $28.86M from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 31.7% from $21.91M in fiscal 2024. Retail & Mail Order Pharmacy was the largest at $20.29M (70.3%), ahead of Marketing & Distribution Of Commercial Products at $8.57M (29.7%).
Compared with fiscal 2024, Retail & Mail Order Pharmacy grew 87.3% to $20.29M, while Marketing & Distribution Of Commercial Products fell 22.6% to $8.57M. From fiscal 2022 to 2025, combined revenue from these segments grew from $23.07M to $28.86M, a compound annual growth rate of 7.8%. Retail & Mail Order Pharmacy's share of the total rose from 33.7% to 70.3%.
Previously Stated was Medicure’s largest revenue line in fiscal 2016, bringing in $29.98M of $29.30M (102%).
| Retrospective Application And Retrospective Restatement | FY 2016 |
|---|---|
| Previously Stated | $29.98M |
| Financial Effect Of Corrections Of Accounting Errors | -$674.83K |
| Total | $29.30M |
Medicure brought in $29.30M from its two revenue lines in fiscal 2016, the year ended December 31, 2016. Previously Stated was the largest at $29.98M (102.3%).
The total is net of Financial Effect Of Corrections Of Accounting Errors, which took $674.83K off revenue in fiscal 2016.
Medicure (MCUJF) reports its revenue by segments [axis] and by retrospective application and retrospective restatement. In fiscal 2025, Retail & Mail Order Pharmacy was its largest segment, bringing in $20.29M (70.3% of the total), followed by Marketing & Distribution Of Commercial Products at $8.57M (29.7%).
Retail & Mail Order Pharmacy was Medicure's largest segment in fiscal 2025, bringing in $20.29M, or 70.3% of the $28.86M total across its two segments.
Previously Stated was Medicure's largest revenue line in fiscal 2016, bringing in $29.98M, or 102.3% of the $29.30M total across its two revenue lines.
Retail & Mail Order Pharmacy grew faster than Marketing & Distribution Of Commercial Products in fiscal 2025, up 87.3% from $10.83M to $20.29M. Marketing & Distribution Of Commercial Products fell 22.6% to $8.57M.
Every figure comes from Medicure's annual financial filings, as reported. Each line keeps the name Medicure gives it, and years follow its fiscal calendar.
Medicure's revenue by segments [axis] goes back to fiscal 2020, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.